Medicine and Dentistry
Human Immunodeficiency Virus
100%
Low and Middle Income Countries
67%
Platelet
61%
Serum Total Protein
57%
Infection
47%
Haemophilia A
47%
Blood Clotting Factor 8 Concentrate
38%
Low Molecular Weight Heparin
38%
COVID-19
38%
Blood Transfusion
38%
Hepatitis C
32%
Blood Proteins
28%
Thrombocyte Function
28%
Knee
25%
Chronic Hepatitis C
24%
Venous Thromboembolism
22%
Echography
22%
Antithrombotic
21%
Deep Vein Thrombosis
21%
Thrombocyte Transfusion
21%
Thrombocyte Preservation
21%
PADGEM Protein
21%
B Lymphocyte
19%
Bleeding
19%
Recombinant Gamma Interferon
19%
Adenocarcinoma
19%
Patient with Non-Hodgkins Lymphoma
19%
Vein Occlusion
19%
Knee Replacement
19%
Thyroid Medullary Carcinoma
19%
Melphalan
19%
Macrophage
19%
Procoagulant
19%
Malignant Neoplasm
19%
Lymphocyte Subpopulation
19%
Apheresis
19%
Sickle-Cell Disease
19%
Atypical Hemolytic Uremic Syndrome
19%
Convalescence
19%
Urokinase
19%
Disease
19%
Phagocytosis
19%
Hip Replacement
19%
Immunosuppressive Treatment
19%
Immune Response
19%
Gas Exchange
19%
Diarrhea
19%
Kidney Transplantation
19%
Tumor Necrosis Factor
19%
Hip Arthroplasty
19%
Immunology and Microbiology
Human Immunodeficiency Virus
99%
Platelet
86%
Blood Plasma
76%
Factor VIII
72%
Phagocytosis
38%
Macrophage
38%
Blood Transfusion
27%
Lymphocyte Subpopulation
24%
CD8
24%
Glycoprotein
21%
Hepatitis C
20%
Cryoprecipitate
20%
Sickle Cell
19%
Monoclonal Antibody
19%
Solution and Solubility
19%
Positron Emission Tomography
19%
Cyclophosphamide
19%
Recombinant Gamma Interferon
19%
Tumor Necrosis Factor Alpha
19%
Hepatic Portal Vein
19%
Pyomyositis
19%
Interleukin 2 Receptor
19%
CD34
19%
Granulocyte Macrophage Colony-Stimulating Factor
19%
Fractionation
16%
Bone Marrow Transplantation
16%
T Cell
15%
Interferon Gamma
14%
CD4 CD8 Ratio
12%
CD4
11%
Prednisolone
9%
Blood Flow
9%
Perfusion
9%
Hypersensitive Response
9%
Vein
9%
Lymphocyte
9%
Conditioning
9%
Monocyte
7%
HLA-DR
6%
Hematopoietic Cell
6%
Myeloid
6%
Engraftment
6%
Colony Forming Unit GM
6%
Cell Cycle
6%
Keyphrases
Hemophiliacs
44%
Factor VIII Concentrate
38%
Immune Parameters
25%
HIV-negative
25%
Platelet Transfusion
22%
Lung Adenocarcinoma
19%
Tranexamic Acid
19%
Coagulation Studies
19%
α2-antiplasmin
19%
Antifibrinolytic Therapy
19%
Microangiopathic Hemolytic Anemia
19%
Antithrombin III (ATIII)
19%
Diffuse Intravascular Coagulation
19%
Coagulation Disorders
19%
Metabolizable Energy
19%
COVID-19 Treatment
19%
Soluble interleukin-2 Receptor (sIL-2R)
19%
Blood Establishments
19%
Chronic Hepatitis C Virus Infection
19%
Multitransfused
19%
Human Immunodeficiency Virus Negative
19%
HIV-negative Patients
19%
Monoclonal Antibody
19%
Glucose Deprivation
19%
HIV Status
19%
Corrected Count Increment
19%
Hemophilia Patients
19%
Platelet Function
19%
Gas Exchange
19%
Low Molecular Weight Heparin
19%
Venous Thromboembolism
19%
Platelets
19%
COVID-19 Convalescent Plasma
19%
CD-8
19%
Factor V Inhibitor
19%
Coagulation Factor V
19%
Previously Treated
19%
Energy Reduction
19%
Immune Suppression
19%
Bacterial Screening
19%
Platelet Preservation
19%
Unfractionated Heparin
13%
HCV RNA
12%
Clinical Consequences
12%
Antimycin A
12%
Transfusion
9%
GPIb
9%
High-dose Steroid Therapy
9%
Plasma-derived Medicinal Products
9%
Alpha Expressions
9%
